The New England journal of medicine, 2021-09, Vol.385 (10), p.908-920
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
- Ist Teil von
- The New England journal of medicine, 2021-09, Vol.385 (10), p.908-920
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Population-based screening showed that men over age 50 with PSA of 3 ng per milliliter or higher and negative MRI results could safely forgo biopsy. Detection of clinically significant cancer among men with positive MRI results who underwent MRI-directed and standard biopsies was similar to that for the standard biopsy group, but the MRI group had fewer findings of clinically insignificant cancers.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2100852Titel-ID: cdi_swepub_primary_oai_prod_swepub_kib_ki_se_147097631
- Format
- –
- Schlagworte
- Aged, Biopsy, Biopsy - methods, Cancer screening, Hematology, Humans, Intention to Treat Analysis, Laboratories, Magnetic Resonance Imaging, Male, Medical screening, Medicin och hälsovetenskap, Middle Aged, Neoplasm Grading, Oncology, Oncology General, Population, Prostate - diagnostic imaging, Prostate - pathology, Prostate cancer, Prostate Disease, Prostate Disease General, Prostate-specific antigen, Prostate-Specific Antigen - blood, Prostatic Neoplasms - diagnostic imaging, Prostatic Neoplasms - pathology, Software, Ultrasonic imaging, Urology